“Ethylaminopyrazine Rifampicin Isoniazid Tablets”, the correct name of which is “Ethylaminopyrazine Rifampicin Isoniazid Tablets”, has been shown to cause dizziness as one of the adverse effects of the drug. Dizziness may be caused by taking Ethylaminopyrazine Rifaximin Tablets, which is a compound preparation consisting of Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol Hydrochloride per tablet. The use of this product is indicated for the intensive treatment of tuberculosis for the first 2 months of short-course therapy. It is contraindicated in people who are allergic to rifampicin, pyrazinamide, isoniazid, ethambutol hydrochloride or any of the excipients, and it is contraindicated in people with severe renal insufficiency, people with abnormal hepatic function, people with biliary obstruction, pregnant women, and people with gout. Ethylaminopyrazine rifaximin tablets have adverse reactions such as headache, dizziness, muscle pain, peripheral neuritis, allergy, etc. It is recommended to use the drug under the guidance of a doctor.